Advertisement

Health


Australia's top 20 cannabis companies

Australia's top 20 cannabis companies

Whether it’s a “gold rush” to secure registration...

Femma: the healthtech helping women access specialist care

Femma: the healthtech helping women access specialist care

Passionate about providing access to quality healthcare, Dr Emma Re...

Integral Diagnostics bolsters clinic presence in QLD with $37.5 million purchase of Exact Radiology

Integral Diagnostics bolsters clinic presence in QLD with $37.5 million purchase of Exact Radiology

Almost three months after buying nine clinics across Southeast Quee...

Cochlear to acquire loss-making Oticon Medical for $170 million

Cochlear to acquire loss-making Oticon Medical for $170 million

Hearing implant maker Cochlear (ASX: COH) is sounding out global co...

Firebrick Pharma kicks off Phase 2 of COVID-19 nasal spray clinical trial

Firebrick Pharma kicks off Phase 2 of COVID-19 nasal spray clinical trial

The second phase of a clinical trial investigating a nasal spray ma...

Advertisement
Advertisement
Advertisement
Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Medicinal cannabis cultivator and manufacturer Little Green Phar...

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about put...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Immutep's EAT COVID trial progresses to the next phase

Immutep's EAT COVID trial progresses to the next phase

A trial of biotechnology company Immutep's (ASX: IMM) experim...

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test t...

Ecofibre signs "milestone" international distribution deal for CBD products

Ecofibre signs "milestone" international distribution deal for CBD products

A new deal between Ecofibre (ASX: EOF) and Sydney-based pharmaceu...

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

After 10 months at the helm of embattled Gold Coast-based dental ...

Pro Medicus pens $40m contract with Utah's largest healthcare provider

Pro Medicus pens $40m contract with Utah's largest healthcare provider

Health imaging company Pro Medicus (ASX: PME) has today announced...

Noxopharm COVID-19 treatment trial advances to the final stage

Noxopharm COVID-19 treatment trial advances to the final stage

A trial of medtech Noxopharm's (ASX: NOX) COVID-19 treatment ...

Skin repair med-tech PolyNovo notches sales growth despite COVID hurdles

Skin repair med-tech PolyNovo notches sales growth despite COVID hurdles

Medical technology company PolyNovo (ASX: PNV) recorded 31 per ce...

Mesoblast shares crash as COVID treatment fails the test

Mesoblast shares crash as COVID treatment fails the test

Shares in Melbourne-based biotech Mesoblast (ASX: MSB) almost hal...

Advertisement

Partner Content

While it is common for businesses to haggle with suppliers over sma...
You may be familiar with traditional ways of earning passive income...
To help meet the rising demand for its construction and engineering...
By now, you’ve surely heard plenty about cryptoassets, their ...
After years of shrinking salaries, Australians began to wonder if t...
The City of Gold Coast (City) is supporting the delivery of an inno...
Beginning its life as a single store startup in Sydney’s tren...
'Digitisation' and 'digitalisation' are two words t...
With the ongoing supply chain crisis expected to continue throughou...
From COVID-19 restrictions changing the way people shop, to supply ...
Advertisement